Delivery Order SPE2DB20D9214-SPE2DB24FD4UH

Award Date 6/5/24
Potential Completion Date 6/27/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,139 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a period of performance through June 12, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,943.40 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a branded pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,415.00 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a...
This is a $17,365.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,020,496 units of the prescription drug PROLASTIN C, with a June 18, 2024 completion date. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $21,664.16 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,365.20 award is for the delivery of 4565030758 PROLASTIN C 1,000 MG/20 ML VLS, which are prescription pharmaceutical products. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,192.44, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialty pharmaceutical product. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, worth up to $4,999,999 through the end of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $14,853.80 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a branded pharmaceutical product, to support the recurring medical supply needs of military health facilities. The order was placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $6,468.00 and covers the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4UH
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,365.20 contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to order a comprehensive range of pharmaceutical items to fulfill the medical requirements of Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation.

Generated 9/4/24, 9:04 AM